Spots Global Cancer Trial Database for A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)
Official Title: Post-Marketing Surveillance (Usage Results Study) of Ixazomib Citrate in Patients With Multiple Myeloma in South Korea
Study ID: NCT04840680
Conditions
Interventions
Study Description
Brief Summary: In this study, people with MM will be treated with ixazomib citrate according to their clinic's standard practice. The main aim of the study is to check for side effects from ixazomib citrate.
Detailed Description: This is a non-interventional, prospective, observational post-marketing surveillance study of ixazomib citrate in participants with MM. The study will assess the safety and effectiveness of ixazomib citrate for its approved indications in a clinical practice setting under real-world conditions. The study will enroll approximately 165 participants. The data will be prospectively collected, at the centers from medical files and recorded into electronic case report forms (e-CRFs). All participants will be enrolled in a single observational group: ⢠Participants With MM The study will be conducted in South Korea. The overall duration of the study will be approximately 6 years and 11 months. Data will be collected over and up to a 6 months-surveillance period (per participant) once enrolled.
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hallym University Sacred Heart Hospital, Anyang, , Korea, Republic of
SOONCHUNHYANG UNIVERSITY HOSPITAL Bucheon, Bucheon, , Korea, Republic of
Inje University Busan Paik Hospital, Busan, , Korea, Republic of
Pusan National University Hospital, Busan, , Korea, Republic of
Kosin University Gospel Hospital, Busan, , Korea, Republic of
Kyungpook National University Hospital, Daegu, , Korea, Republic of
Keimyung University Dongsan Hospital, Daegu, , Korea, Republic of
Chungnam National Unversity Hospital, Daejeon, , Korea, Republic of
Chonnam National University Hwasun Hospital, Hwasun, , Korea, Republic of
The Catholic University of Korea, Incheon ST. Marys Hospital, Incheon, , Korea, Republic of
Korea University Anam Hospital, Seoul, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Samsung medical center, Seoul, , Korea, Republic of
The Catholic University of Korea Seoul ST. Mary's Hospital, Seoul, , Korea, Republic of
Chung-Ang University Hospital, Seoul, , Korea, Republic of
Ewha womans university medical center, Seoul, , Korea, Republic of
Korea University Guro Hospital, Seoul, , Korea, Republic of
Ajou University Hospital, Suwon, , Korea, Republic of
Yonsei University Wonju Severance Christian Hospital, Wonju, , Korea, Republic of
Yongin Severance Hospital, Yongin, , Korea, Republic of
Contact Details
Name: Study Director
Affiliation: Takeda
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
